


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 21 Dec 2017
Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)
Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)
HSMN NewsFeed - 20 Dec 2017
Amneal Brings Generic for Renvela(R) to Market and Starts December Strong with Six Product Launches
Amneal Brings Generic for Renvela(R) to Market and Starts December Strong with Six Product Launches
HSMN NewsFeed - 19 Dec 2017
Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer
Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer
HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
HSMN NewsFeed - 14 Dec 2017
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
HSMN NewsFeed - 13 Dec 2017
Kangen Pharmaceuticals Co., Ltd. Announces Acquisition Of KC Specialty Therapeutics
Kangen Pharmaceuticals Co., Ltd. Announces Acquisition Of KC Specialty Therapeutics
HSMN NewsFeed - 13 Dec 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 7 Dec 2017
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 5 Dec 2017
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
HSMN NewsFeed - 4 Dec 2017
Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
HSMN NewsFeed - 4 Dec 2017
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
HSMN NewsFeed - 30 Nov 2017
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
HSMN NewsFeed - 29 Nov 2017
Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
HSMN NewsFeed - 29 Nov 2017
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
HSMN NewsFeed - 28 Nov 2017
Upsher-Smith Launches KLOR-CON(R) Powder (Potassium Chloride) For Oral Solution
Upsher-Smith Launches KLOR-CON(R) Powder (Potassium Chloride) For Oral Solution
HSMN NewsFeed - 27 Nov 2017
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
HSMN NewsFeed - 27 Nov 2017
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
HSMN NewsFeed - 16 Nov 2017
FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
HSMN NewsFeed - 10 Nov 2017
Medivir Appoints Christina Herder as Executive Vice President Strategic Business Development
Medivir Appoints Christina Herder as Executive Vice President Strategic Business Development
HSMN NewsFeed - 9 Nov 2017
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
HSMN NewsFeed - 2 Nov 2017
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
HSMN NewsFeed - 2 Nov 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
